Product Information
BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE is a generic product labeled by Sandoz Inc., priced at $0.9687 per EA under NDC 00781227001. Its NADAC has been published 94 times since Nov 6, 2024.
FDA first approved this application on Oct 11, 1985. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Sandoz Inc.NDC
00781227001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ASPIRIN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA086996FDA Approved
10/11/1985
TE Code
AA
On Market Since
9/3/2024
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has been published 94 times since Nov 6, 2024, and over the history we have for it it has risen 29.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9687 per EA |
|---|---|
| All-time high | $1.0486 (Sep 10, 2025) |
| All-time low | $0.3623 (Nov 20, 2024) |
| 52-week high | $1.0486 |
| 52-week low | $0.9687 |
| Median price | $0.9792 |
| Average price | $0.9153 |
| Largest weekly change | +59.7% (Dec 18, 2024) |
| Weeks tracked | 94 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE, manufactured by Sandoz Inc., is $0.9687 per EA (NDC 00781227001), effective Aug 19, 2026.
How has the price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has risen 29.2%. It has been tracked across 94 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?
Since Nov 6, 2024, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has ranged from a low of $0.3623 (Nov 20, 2024) to a high of $1.0486 (Sep 10, 2025), with a median of $0.9792 per EA.
Are there cheaper alternatives to BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?
BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE (NDC 00781227001) is labeled by Sandoz Inc., and CMS classifies it as a generic product.